John P. McLaughlin
2018
In 2018, John P. McLaughlin earned a total compensation of $4.1M as Former Chief Executive Officer at PDL BioPharma, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,188,356 |
|---|---|
| Option Awards | $2,133,531 |
| Salary | $700,057 |
| Other | $71,225 |
| Total | $4,093,169 |
McLaughlin received $2.1M in option awards, accounting for 52% of the total pay in 2018.
McLaughlin also received $1.2M in non-equity incentive plan, $700.1K in salary and $71.2K in other compensation.
Rankings
In 2018, John P. McLaughlin's compensation ranked 2,712th out of 14,244 executives tracked by ExecPay. In other words, McLaughlin earned more than 81.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,712 out of 14,244 | 81st |
Division Manufacturing | 1,003 out of 5,759 | 83rd |
Major group Chemicals And Allied Products | 350 out of 2,122 | 84th |
Industry group Drugs | 287 out of 1,811 | 84th |
Industry Biological Products, Except Diagnostic Substances | 61 out of 339 | 82nd |
Source: SEC filing on April 30, 2019.
McLaughlin's colleagues
We found four more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2018.